Page 119 - v11i4
P. 119

International Journal of Bioprinting                                3D bioprinting for translational toxicology




            with robotic handling, as shown in  Figure 5A. This   and fibrinogen bioinks, they successfully constructed
            system employs a sealed, 3D-printed microfluidic chip   a multicellular, vascularized hepatocellular carcinoma
            featuring a central tissue chamber flanked by arterio-  model. The platform’s automation dramatically enhances
            venous  mimic  channels,  laying  the  groundwork  for   both efficiency and reproducibility, and in a HepG2 model,
            microvascular network self-assembly. By utilizing agarose   it demonstrated stable microvascular network formation,

























































            Figure 5. Applications of three-dimensional (3D) printing in organ-on-a-chip design. (A) Schematic of the automated fabrication workflow for vascularized
            organs-on-chips (OOCs). (a) A robotic platform precisely loads and unloads custom microfluidic chips during the pre- and post-processing stages of
            3D bioprinting. (b) Within the chip’s tissue chamber, printed HepG2 cells proliferate into spheroidal aggregates as a perfusable microvascular network
                                                                 159
            self-assembles over the culture period. Adapted with permission from Fritschen et al.  (B) Tumor-on-a-chip with bioprinted blood-lymphatic pair (TOC-
            BBL). (a) Schematic of TOC-BBL featuring adjacent bioprinted blood and lymphatic vessels. (b) Overview of the custom 3D-printing setup and fabrication
            workflow for TOC-BBL. (c) Viability quantification of cells within the TOC-BBL platform. (d) Doxorubicin (DOX) dose-response curves for MCF-7 cells in
            two-dimensional culture versus 3D TOC-BBL. (e) Fluorescence micrographs showing MCF-7 viability under increasing DOX concentrations (p < 0.01). Scale
                                              162
            bar: 100 µm. Adapted with permission from Cao et al.  Copyright © 2019 Wiley-VCH. (C) Integration of multiple tissues in a modular organ-on-a-chip
            platform. (a & b) Diagrams and images of the plug-and-play system enabling parallel culture of three tissue types via interconnected microreactors. (c) Liver
            and cardiac modules are generated by printing spheroids within custom bioinks. (d) Lung models are developed by layering cells over porous membranes,
            with transendothelial electrical resistance (TEER) sensors integrated for barrier integrity monitoring. Adapted with permission from Skardal et al. 165

            Volume 11 Issue 4 (2025)                       111                            doi: 10.36922/IJB025210209
   114   115   116   117   118   119   120   121   122   123   124